Madrigal Pharmaceuticals Inc (MDGL)
329.24
+12.15
(+3.83%)
USD |
NASDAQ |
Nov 21, 16:00
Madrigal Pharmaceuticals Total Assets (Quarterly): 1.073B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.073B |
| June 30, 2024 | 1.100B |
| March 31, 2024 | 1.082B |
| December 31, 2023 | 640.55M |
| September 30, 2023 | 237.96M |
| June 30, 2023 | 302.46M |
| March 31, 2023 | 332.45M |
| December 31, 2022 | 362.57M |
| September 30, 2022 | 158.64M |
| June 30, 2022 | 216.39M |
| March 31, 2022 | 222.66M |
| December 31, 2021 | 273.33M |
| September 30, 2021 | 304.70M |
| June 30, 2021 | 327.96M |
| March 31, 2021 | 309.73M |
| December 31, 2020 | 287.00M |
| September 30, 2020 | 339.62M |
| June 30, 2020 | 388.39M |
| March 31, 2020 | 411.46M |
| December 31, 2019 | 442.06M |
| September 30, 2019 | 456.25M |
| June 30, 2019 | 469.82M |
| March 31, 2019 | 479.56M |
| December 31, 2018 | 485.43M |
| September 30, 2018 | 489.55M |
| Date | Value |
|---|---|
| June 30, 2018 | 491.53M |
| March 31, 2018 | 183.48M |
| December 31, 2017 | 192.31M |
| September 30, 2017 | 62.83M |
| June 30, 2017 | 68.07M |
| March 31, 2017 | 40.36M |
| December 31, 2016 | 41.21M |
| September 30, 2016 | 41.51M |
| June 30, 2016 | 44.94M |
| March 31, 2016 | 52.97M |
| December 31, 2015 | 0.3636M |
| September 30, 2015 | 91.01M |
| June 30, 2015 | 101.54M |
| March 31, 2015 | 79.39M |
| December 31, 2014 | 100.68M |
| September 30, 2014 | 123.66M |
| June 30, 2014 | 115.95M |
| March 31, 2014 | 82.18M |
| December 31, 2013 | 95.20M |
| September 30, 2013 | 56.66M |
| June 30, 2013 | 73.92M |
| March 31, 2013 | 93.70M |
| December 31, 2012 | 103.02M |
| September 30, 2012 | 57.61M |
| June 30, 2012 | 47.16M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
158.64M
Minimum
Sep 2022
1.100B
Maximum
Jun 2024
440.66M
Average
330.20M
Median
Total Assets (Quarterly) Benchmarks
| Corcept Therapeutics Inc | 784.26M |
| ADMA Biologics Inc | 390.62M |
| 89bio Inc | 458.30M |
| Sarepta Therapeutics Inc | 3.600B |
| Matinas BioPharma Holdings Inc | 20.58M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 296.11M |
| Shareholders Equity (Quarterly) | 777.16M |
| Debt to Equity Ratio | 0.1507 |
| Current Ratio | 5.981 |
| Net Debt Paydown Yield | -0.08% |